Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Eli Lilly NYSE:LLY |
1.008,93 B | 23,47% | 6/6 | 38,18% | 3,56% | 10,57% | UP |
|
Merck NYSE:MRK |
297,02 B | 7,71% | 6/6 | -21,58% | -15,73% | 12,26% | UP |
|
AstraZeneca PLC LSE:AZN |
210,22 B | 8,90% | 5/6 | 9,73% | -20,11% | 23,34% | UP |
|
Pfizer NYSE:PFE |
148,41 B | 7,82% | 3/6 | -4,89% | 24,13% | 7,53% | UP |
|
Sanofi ENXTPA:SAN |
91,75 B | 5,26% | 5/6 | 8,12% | 19,81% | 29,51% | DOWN |
|
argenx ENXTBR:ARGX |
45,32 B | 81,26% | 5/6 | 41,11% | 30,21% | 19,37% | UP |
|
Teva Pharmaceutical Industries NYSE:TEVA |
40,09 B | 1,20% | 4/6 | -11,54% | -183,89% | 16,18% | UP |
|
Viatris NasdaqGS:VTRS |
18,52 B | -3,61% | 5/6 | 3,43% | -59,91% | 13,21% | UP |
|
Genmab A/S CPSE:GMAB |
97,22 B | 14,27% | 4/6 | -5,87% | 56,95% | 45,25% | DOWN |
|
Recordati Industria Chimica e Farmaceutica S.p.A. BIT:REC |
10,30 B | 10,99% | 5/6 | 4,25% | 19,30% | 13,52% | UP |
|
Orion Oyj HLSE:ORNBV |
9,73 B | 15,02% | 5/6 | 8,72% | 7,00% | 14,24% | UP |
|
ALK-Abelló A/S CPSE:ALK B |
58,98 B | 32,62% | 5/6 | 20,28% | 20,38% | 12,70% | UP |
|
Alkermes NasdaqGS:ALKS |
7,23 B | 20,76% | 5/6 | -57,15% | -41,16% | 3,73% | UP |
|
Hikma Pharmaceuticals PLC LSE:HIK |
3,11 B | 0,90% | 3/6 | 1,72% | 18,87% | 27,74% | DOWN |
|
Zealand Pharma A/S CPSE:ZEAL |
22,92 B | 70,97% | 4/6 | -52,34% | 87,35% | 44,35% | DOWN |
|
Almirall BME:ALM |
2,40 B | -7,36% | 3/6 | 34,10% | 19,42% | 28,58% | DOWN |
|
Pharma Mar BME:PHM |
1,64 B | -7,99% | 1/6 | -24,71% | -8,72% | 27,32% | UP |
|
Faes Farma BME:FAE |
1,42 B | 3,33% | 3/6 | 17,85% | -8,59% | 17,72% | UP |
|
Cosmo N.V. SWX:COPN |
1,20 B | 12,72% | 4/6 | 174,36% | -38,75% | 75,87% | DOWN |
|
MedinCell ENXTPA:MEDCL |
0,96 B | 11,93% | 4/6 | 6,02% | -58,07% | 24,81% | UP |
